Lauren Daskivich is an Ophthalmology physician affiliated with University of Southern California. OpenAlex indexes 34 publications with 357 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20255 payments
- Johnson & Johnson Surgical Vision, Inc.Program year20251 payment
- Alcon Vision LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
100%Prostaglandin Analog55.3%Latanoprost100%Part D<11 patientsalpha-Adrenergic Agonist44.7%Brimonidine Tartrate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2019–2022 per NIH RePORTER. The latest:
- Predicting Diabetic Retinopathy from Risk Factor Data and Digital Retinal Images
Charles R. Drew University of Med & Sci
FY2022$398,313R01LM012309 - Predicting Diabetic Retinopathy from Risk Factor Data and Digital Retinal Images
Charles R. Drew University of Med & Sci
FY2021$399,963R01LM012309 - Predicting Diabetic Retinopathy from Risk Factor Data and Digital Retinal Images
Charles R. Drew University of Med & Sci
FY2019$512,263R01LM012309
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Siamak Daneshmand, MD
University of Southern California
David Freyer, DO
University of Southern California
Andrew Moshfeghi, MD
University of Southern California
Robert Weinreb, MD
University of California San Diego
Emily Chew, MD
National Eye Institute
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”